TriMas
TriMas' revenue rose 2.4% to $646 million in fiscal 2025. Its operating margin was 6.4%, up from 2.4% a year earlier. Free cash flow was $69 million, up 439.0%. It paid out $110 million in dividends and buybacks, 159% of free cash flow. The diluted share count rose 0.2%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What TriMas does
TriMas, based in Bloomfield Hills, Michigan, designs and makes a mix of products mainly for consumer products, aerospace and defense, and industrial markets. It is organized into TriMas Packaging, TriMas Aerospace and Specialty Products groups. Packaging makes items such as caps, closures, pumps and dispensers. Specialty Products includes Norris Cylinder, a maker of high- and low-pressure cylinders. The company has approximately 3,700 employees at 37 manufacturing and support locations in 13 countries.
On November 4, 2025, TriMas agreed to sell TriMas Aerospace to an affiliate of Tinicum and funds managed by Blackstone. The purchase price is approximately $1.45 billion in cash, and the sale is expected to close in the first quarter of 2026. Because of the sale, the company shows Aerospace as a discontinued operation. Its results for continuing operations cover the rest of the business: net sales were $645.7 million in 2025, and about 66% of them came from North America.
TriMas says many of its products are customized for its customers, for example caps and closures with tailored colors, sizes and dispensing features, and that it has long relationships with many of them. It competes in markets it describes as highly competitive.
Its biggest risks, as it describes them
- Weaker sales and margins when the economy slows or customers in cyclical industries cut back.
- Competition in many of its markets that could limit sales volumes and reduce margins.
- A more concentrated customer base, and the loss of key customers or critical suppliers.
- Higher raw material or energy costs, and shifts in U.S. trade policy.
- Buying and selling businesses, including the sale of Aerospace, which can bring unexpected liabilities.
Income statement
From fiscal 2017 to 2025, earnings per share grew 20.4% a year and net income 18.4% a year, as buybacks cut the share count by 11%.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 141 | 112 | 35 | 23 | 30 |
| Debt incl. finance leases | 400 | 400 | 402 | 403 | 474 |
| Net debt (negative means net cash) | 259 | 288 | 367 | 380 | 444 |
| Net debt to EBITDA | 1.8x | 1.9x | 3.4x | 4.8x | 4.5x |
| Debt to equity | 0.6x | 0.6x | 0.6x | 0.6x | 0.7x |
| Interest coverage | 6.5x | 7.0x | 3.2x | 0.8x | 2.3x |
| Current ratio | 2.8x | 3.0x | 2.5x | 2.7x | 2.5x |
| Quick ratio | 1.8x | 1.9x | 1.3x | 2.0x | 1.9x |
Cash flow
Projections
Project TriMas' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
What TriMas says to expect
- Full year 2026: adjusted earnings per share
The Company has reaffirmed its adjusted diluted earnings per share (2) (EPS) outlook for full-year 2026 of $1.60 to $1.70.
- Full year 2026: sales growth
The Company now expects 4% to 6% year-over-year sales growth across its combined Packaging and Specialty Products businesses, a modest increase from its prior outlook of 3% to 6%.
- Full year 2026: adjusted operating profit margin
The Company also expects approximately 250 basis points of adjusted operating profit margin expansion year-over-year, reflecting the benefits of cost-reduction actions and organizational realignment initiatives, partially offset by the extended throughput challenges within Specialty Products.
Insider trades
Over the 12 months between November 14, 2025 and November 13, 2026, 1 insider bought $9,927 of TriMas shares on the open market, and 2 insiders sold $881,970, $675,450 of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Daniel P TredwellDirector | Bought | 67 | $37.73 | $2,527 | Form 4 |
| Aug 12, 2026 | Daniel P TredwellDirector | Bought | 64 | $39.63 | $2,524 | Form 4 |
| Jun 30, 2026 | Herbert K ParkerDirector | Sold plan | 15,000 | $45.03 | $675,450 | Form 4 |
| May 13, 2026 | Daniel P TredwellDirector | Bought | 62 | $40.58 | $2,522 | Form 4 |
| May 7, 2026 | Jodi F. RobinGeneral Counsel and Secretary | Sold | 2,000 | $41.61 | $83,220 | Form 4 |
| May 5, 2026 | Jodi F. RobinGeneral Counsel and Secretary | Sold | 3,000 | $41.10 | $123,300 | Form 4 |
| Mar 5, 2026 | Daniel P TredwellDirector | Bought | 60 | $39.38 | $2,354 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 5 of 9 | 6 of 9 | 5 of 9 |
| Rule of 40 | −21.0% | −1.2% | 13.1% |
| Altman Z'' | 2.52 | 2.52 | 2.65 |
| Accruals ratio | −3.6% | −3.0% | 0.2% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Fail | Pass |
| Cash from operations exceeds net income | Pass | Pass | Fail |
| Debt fell relative to assets | Pass | Pass | Fail |
| Current ratio rose | Fail | Pass | Fail |
| Share count didn't rise | Pass | Pass | Fail |
| Gross margin rose | Fail | Fail | Pass |
| Revenue rose relative to assets | Fail | Fail | Pass |
| F-score | 5 of 9 | 6 of 9 | 5 of 9 |
Compare
Put TriMas side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| TriMas | FY25 | 2.4% | 6.4% | 10.7% | 3.8% | 4.5x | 5 | |
| Myers Industries | FY25 | −1.3% | 9.0% | 8.1% | 9.4% | 3.4x | 6 | Compare |
| AptarGroup | FY25 | 5.4% | 13.3% | 7.9% | 11.4% | 1.4x | 7 | Compare |
| Greif | FY25 | −9.7% | 4.3% | −2.2% | 1.9% | 2.4x | — | Compare |
| O-I Glass | FY25 | −1.6% | — | 2.6% | 4.2% | 5.5x | 6 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 794 | 656 | 705 | 724 | 770 | 857 | 884 | 652 | 631 | 646 |
| Revenue growth | −8.1% | −17.4% | 7.5% | 2.6% | 6.4% | 11.3% | 3.1% | −26.2% | −3.3% | 2.4% |
| Gross profit | 211 | 189 | 200 | 194 | 182 | 217 | 208 | 153 | 130 | 138 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | −42 | 93 | 109 | 91 | −88 | 95 | 99 | 51 | 15 | 41 |
| Net income | −40 | 31 | 83 | 99 | −80 | 57 | 66 | 40 | 24 | 120 |
| Diluted EPS (US$) | −0.88 | 0.67 | 1.80 | 2.16 | −1.83 | 1.32 | 1.56 | 0.97 | 0.60 | 2.95 |
| Diluted shares (millions) | 45 | 46 | 46 | 46 | 44 | 43 | 42 | 42 | 41 | 41 |
| Cash flow | ||||||||||
| Cash from operations | 80 | 120 | 129 | 76 | 127 | 134 | 73 | 88 | 64 | 117 |
| Capital expenditure | 31 | 34 | 23 | 30 | 40 | 45 | 46 | 54 | 51 | 48 |
| Free cash flow | 49 | 86 | 106 | 46 | 87 | 89 | 27 | 34 | 13 | 69 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 2 | 7 | 7 | 7 | 7 |
| Share buybacks | 0 | 0 | 12 | 37 | 39 | 19 | 37 | 19 | 19 | 103 |
| Acquisitions | 0 | 0 | 0 | 67 | 194 | 34 | 64 | 77 | 0 | 38 |
| Stock-based compensation | 7 | 7 | 7 | 6 | 8 | 10 | 10 | 10 | 7 | 12 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 21 | 28 | 108 | 172 | 74 | 141 | 112 | 35 | 23 | 30 |
| Debt incl. finance leases | 379 | 311 | 300 | 300 | 350 | 400 | 400 | 402 | 403 | 474 |
| Total assets | 1,052 | 1,033 | 1,100 | 1,193 | 1,194 | 1,304 | 1,305 | 1,342 | 1,324 | 1,485 |
| Total liabilities | 552 | 489 | 480 | 495 | 610 | 673 | 653 | 659 | 657 | 780 |
| Shareholders' equity | 500 | 544 | 620 | 698 | 584 | 631 | 652 | 683 | 667 | 706 |
| Margins and ratios | ||||||||||
| Gross margin | 26.6% | 28.9% | 28.4% | 26.8% | 23.6% | 25.3% | 23.6% | 23.5% | 20.5% | 21.4% |
| Operating margin | −5.3% | 14.1% | 15.4% | 12.6% | −11.5% | 11.1% | 11.2% | 7.8% | 2.4% | 6.4% |
| Net margin | −5.0% | 4.7% | 11.8% | 13.6% | −10.4% | 6.7% | 7.5% | 6.2% | 3.8% | 18.6% |
| Free cash flow margin | 6.2% | 13.2% | 15.0% | 6.3% | 11.3% | 10.4% | 3.0% | 5.2% | 2.0% | 10.7% |
| Rule of 40 (growth + FCF margin) | −1.9% | −4.2% | 22.5% | 9.0% | 17.7% | 21.7% | 6.1% | −21.0% | −1.2% | 13.1% |
| Return on capital | −3.7% | 5.7% | 10.6% | 8.8% | −8.3% | 9.0% | 8.2% | 4.2% | 1.1% | 3.8% |
| Return on equity | −7.6% | 5.9% | 14.3% | 15.0% | −12.4% | 9.4% | 10.3% | 6.0% | 3.6% | 17.5% |
| Return on assets | −3.6% | 3.0% | 7.8% | 8.6% | −6.7% | 4.6% | 5.1% | 3.0% | 1.8% | 8.6% |
| Net debt to EBITDA | 122.4x | 2.1x | 1.3x | 0.9x | — | 1.8x | 1.9x | 3.4x | 4.8x | 4.5x |